Trp2063and Trp2064in the Factor Va C2 Domain Are Required for High-Affinity Binding to Phospholipid Membranes but Not for Assembly of the Prothrombinase Complex
- 19 March 2004
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 43 (14) , 4385-4393
- https://doi.org/10.1021/bi035763o
Abstract
Interactions between factor Va and membrane phosphatidylserine (PS) regulate activity of the prothrombinase complex. Two solvent-exposed hydrophobic residues located in the C2 domain, Trp2063 and Trp2064, have been proposed to contribute to factor Va membrane interactions by insertion into the hydrophobic membrane bilayer. However, the prothrombinase activity of rHFVa W(2063, 2064)A was found to be significantly impaired only at low concentrations of PS (5 mol %). In this study, we find that 10-fold higher concentrations of mutant factor Va are required for half-maximal prothrombinase activity on membranes containing 25% PS. The ability of the mutant factor Va to interact with factor Xa on a membrane was also impaired since 4-fold higher concentrations of factor Xa were required for half-maximal prothrombinase activity. The interaction of factor Va with 25% PS membranes was also characterized using fluorescence energy transfer and surface plasmon resonance. We found that the affinity of mutant factor Va for membranes containing 25% PS was reduced at least 400-fold with a Kd > 10-7 M. The binding of mutant factor Va to 25% PS membranes was markedly enhanced in the presence of factor Xa, indicating stabilization of the factor Va−factor Xa−membrane complex. Our findings indicate that Trp2063 and Trp2064 play a critical role in the high-affinity binding of factor Va to PS membranes. It remains to be determined whether occupancy of this PS binding site in factor Va is also required for high-affinity binding to factor Xa.Keywords
This publication has 15 references indexed in Scilit:
- Role of P-selectin, β2-integrins, and Src tyrosine kinases in mouse neutrophil–platelet adhesionJournal of Thrombosis and Haemostasis, 2003
- Mutations in a potential phospholipid binding loop in the C2 domain of factor V affecting the assembly of the prothrombinase complexBlood Coagulation & Fibrinolysis, 2000
- Principles of Fluorescence SpectroscopyPublished by Springer Nature ,1999
- Lipid–protein interactions in blood coagulationBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1998
- Activation of Factor VIII by Thrombin Increases Its Affinity for Binding to Synthetic Phospholipid Membranes and Activated PlateletsJournal of Biological Chemistry, 1998
- Insights into the complex association of bovine factor Va with acidic-lipid-containing synthetic membranesBiophysical Journal, 1996
- Localization of functionally important epitopes within the second C-type domain of coagulation factor V using recombinant chimeras.Journal of Biological Chemistry, 1994
- Characterization of an acquired inhibitor to coagulation factor V. Antibody binding to the second C-type domain of factor V inhibits the binding of factor V to phosphatidylserine and neutralizes procoagulant activity.Journal of Clinical Investigation, 1992
- Identification and characterization of a phospholipid-binding site of bovine factor Va.Journal of Biological Chemistry, 1990
- Changes in membrane phospholipid distribution during platelet activationBiochimica et Biophysica Acta (BBA) - Biomembranes, 1983